Direct Rx recalls Glimepiride, USP, 2 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0488-30; b) 90-count bottle, NDC 61
Recalled April 5, 2023 · FDA recall D-0481-2023 · Direct Rx
Hazard
cGMP deviations · FDA Class II
Units
30 count: 12 bottles; 90 count: 253 bottles
Sold at
Nationwide in the USA
Description
cGMP deviations
Product
Glimepiride, USP, 2 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0488-30; b) 90-count bottle, NDC 61919-0448-90 Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534
Manufacturer(s)
Direct Rx
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →